Dindolyl Methane, or DIM as it’s more commonly referred to, is a popular supplement for bodybuilders as well as others who are interested in increasing the growth of their muscles. Recent studies have shown that DIM could pose health risks. DIM can cause liver damage when taken in excessive amounts. Another risk is kidney damage, which could lead to kidney failure. The long-term health risks of DIM have many bodybuilders and athletes ask the question: should I take a supplement with DIM?
To boost testosterone production, most people take a diindolylmethane supplement. It is known that testosterone functions as an androgen. This means that it can trigger hormonal changes in tissues. Research has shown DIM to mimic the effects both of testosterone and other hormones. Because men produce much more testosterone than women do Some manufacturers have added diindolylmethane to their products in order to boost their competitiveness in male circles. Men will react to products that mimic testosterone naturally.
As a result, numerous companies promote DIM as a cancer suppressor. While diindolylmethane has been proven effective in reducing tumor growth in laboratory animals it was given orally to the animals. To achieve the same result in humans, diindolylmethane needs to be consumed in large doses for a long period of time. The animals studied did not show any symptoms of cancer for several years. However, they all developed liver disease due to consuming excessive amounts of diindolylmethane. For a thorough understanding of the way DIM works in the body, you should contact a medical practitioner.
According to the US National Institute of Environmental Health Safety and Security, the only way to show that DIM is effective in treating breast cancer is to conduct an experiment wherein cells from healthy breast cancer cells are exposed to high doses of diindolylmethane over a period of time. There are pros and negatives to using DIM just like any chemical. The ability to mimic hormones is one of the advantages. This allows you to create insulin that can stop the growth of cancer cells. The downside is that diindolylmethane produces a harmful chemical called DMSO. Know more about 3 3 diindolylmethane now.
One of the most common claims made for diindolylmethane as a treatment for various health problems is that it acts as a natural, anti-fungal, anti-bacterial, and anti-cancer agent. The National Institute of Health, through a thorough review of supportive data concluded that there was no basis for these claims. According to the Institute of Chemical Technology, there were no studies conducted to prove this claim. The Institute of Chemical Safety, in their in-depth analysis of the safety profile for the firestone concluded that the evidence provided by pharmaceutical companies regarding the benefits of diindolylmethane for humans were not entirely reliable.
Van der Goes and. and. published their findings in a May 2021 issue of the Journal of Toxicology and Environmental Health. Van der Goes, and. identified the potential dangers of diindolylmethane usage, which include allergic reactions to the skin asthma attacks, as well as dizziness, headaches and respiratory problems. They also stated that the recommended daily dose for this chemical is 0.2 milligrams, which is about one tenth of one teaspoon. It is not clear what the level of concentration is when it is compounded with other compounds. This substance isn’t safe because it hasn’t been thoroughly tested.
The view abstract indicates that the use of diindolylmethane (DIEM) in the context of treating cancer is based on the concept of inhibiting intracellular inhibition of pyruvate metabolite by flavenoids, and thereby stopping the accumulation of oxalates within renal tubule cells as well as adenine granulocytes. However, the drug metabiplicate toxicology studies did not provide convincing evidence that consumption of this chemical causes an overdose. The Food and Drug Administration approved the substance as a prescription drug in June 1996. According to the FDA the company that manufactures firestone Tincture is currently completing two major tests in Europe and the United States.
The abstract of the view also indicates that diindolylmethane’s usage in cancer treatment is based on the idea of inhibiting intracellular inhibition through flavenoids of pyruvate metabolism , and thus stopping the accumulation of oxalates and adenine in renal tubule cells. The drug metabiplicate toxicology studies have not demonstrated that this chemical is able to cause overdose. In June 1996, the Food and Drug Administration approved this drug as a prescription drug. According to the FDA the manufacturer of firestone tincture is in process of completing two major studies – one in Europe and one in the United States. According to FDA, the FDA states that the manufacturer of firestone Tincture is currently conducting two major trials in Europe as well as one in the United States.